Suchergebnisse - (Subject:"2494G1JF75")

PubPharm (71)

1

Aspartic peptidase of Phialophora verrucosa as target of HIV peptidase inhibitors : blockage of its enzymatic activity and interference with fungal growth and macrophage interaction

enthalten in: Journal of enzyme inhibition and medicinal chemistry | 2020

von Granato, M. | Sousa, I. | Rosa, T. | +6

2

Pharmacokinetic Interactions between the Hepatitis C Virus Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, and Darunavir in Healthy Volunteers

enthalten in: Antimicrobial agents and chemotherapy | 2019

von Feng, H. | Caro, L. | Fandozzi, C. | +21

3

GRL-079, a Novel HIV-1 Protease Inhibitor, Is Extremely Potent against Multidrug-Resistant HIV-1 Variants and Has a High Genetic Barrier against the Emergence of Resistant Variants

enthalten in: Antimicrobial agents and chemotherapy | 2018

von Delino, N. | Aoki, M. | Hayashi, H. | +7

4

A Modified P1 Moiety Enhances In Vitro Antiviral Activity against Various Multidrug-Resistant HIV-1 Variants and In Vitro Central Nervous System Penetration Properties of a Novel Nonpeptidic Protease Inhibitor, GRL-10413

enthalten in: Antimicrobial agents and chemotherapy | 2016

von Amano, M. | Salcedo-Gómez, P. | Zhao, R. | +7

5

HIV protease inhibitors disrupt astrocytic glutamate transporter function and neurobehavioral performance

enthalten in: AIDS (London, England) | 2016

von Vivithanaporn, P. | Asahchop, E. | Acharjee, S. | +2

6

GRL-04810 and GRL-05010, difluoride-containing nonpeptidic HIV-1 protease inhibitors (PIs) that inhibit the replication of multi-PI-resistant HIV-1 in vitro and possess favorable lipophilicity that may allow blood-brain barrier penetration

enthalten in: Antimicrobial agents and chemotherapy | 2013

von Salcedo Gómez, P. | Amano, M. | Yashchuk, S. | +4

7

GRL-0519, a novel oxatricyclic ligand-containing nonpeptidic HIV-1 protease inhibitor (PI), potently suppresses replication of a wide spectrum of multi-PI-resistant HIV-1 variants in vitro

enthalten in: Antimicrobial agents and chemotherapy | 2013

von Amano, M. | Tojo, Y. | Salcedo-Gómez, P. | +7

8

Interaction between HIV protease inhibitors (PIs) and hepatic transporters in sandwich cultured human hepatocytes : implication for PI-based DDIs

enthalten in: Biopharmaceutics & drug disposition | 2013

von Liu, L. | Unadkat, J.

9

Lipid-lowering effect and efficacy after switching to etravirine in HIV-infected patients with intolerance to suppressive HAART

enthalten in: HIV clinical trials | 2013

von Casado, J. | de Los Santos, I. | Del Palacio, M. | +4

10

HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy : the ANRS EP45 "aging" study

enthalten in: PloS one | 2012

von Perrin, S. | Cremer, J. | Faucher, O. | +15

ErratumIn: PLoS One. 2013;8(8). doi:10.1371/annotation/f02cdfd3-b271-46fd-a78f-5a030f0b416d Tamalet, Corine Nicolino-Brunet Catherine [corrected to Nicolino-Brunet, Corinne]; [ corrected to Tamalet, Catherine]

1
2
3
4
5
6
7
8
Nächster »
[8]